Valganciclovir - Simmaron Research

You are here: Simmaron Research Pathogens Viral Finding May Open Treatment Possibilities for 15-20K Chronic Fatigue Syndrome Patients in the U.S.Valganciclovir

Valganciclovir

August 1, 2013

Valganciclovir (Valcyte) is effective against HHV-6; (valaciyclovir) Valtrex is not

Print Friendly, PDF & Email

Twitter Facebook

Leave a Reply

@RedefiningMECFS Latest Tweets

#GRATITUDE : What we feel toward every single one of our amazing donors/supporters. #SimmaronShoutOut : Today, ou… https://t.co/FQl1Bh4mlg, Aug 14
It’s the last week of work for our summer 2019 intern cohort. The SRI team is proud of these students and all they’… https://t.co/UuNfk3Wy6p, Aug 5
Stay hydrated with SRI #swag! From now through August 1st, the SRI team will gift a tumbler cup to each person who… https://t.co/KSTMaMzsGm, Jul 25

Follow @RedefiningMECFS

Copyright 2019 • Simmaron Research • Simmaron Research Inc. is a Non-Profit 501(c)(3)